Public Profile

Kedrion

Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Kedrion's score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

Kedrion's reported carbon emissions

In 2022, Kedrion reported total carbon emissions of approximately 30,122,000 kg CO2e from Scope 1 and 35,982,000 kg CO2e from Scope 2. This marks a significant increase in emissions compared to 2021, where emissions were about 16,894,000 kg CO2e for Scope 1 and 25,581,000 kg CO2e for Scope 2. The data indicates a trend of rising emissions over the past few years, with 2020 emissions recorded at approximately 32,736,000 kg CO2e for Scope 1 and 21,143,000 kg CO2e for Scope 2. Kedrion has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of Scope 3 emissions data suggests a limited understanding of their full environmental impact. As a company headquartered in Italy, Kedrion's climate commitments and strategies remain unclear, highlighting a potential area for improvement in transparency and sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2019202020212022
Scope 1
2,421
00,000,000
00,000,000
00,000,000
Scope 2
21
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kedrion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kedrion is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kedrion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ADMA Biologics, Inc.

US
Health and social work services (85)
Updated 3 days ago

Harmonic Drive Systems

JP
Computer and related services (72)
Updated 3 days ago

Saol Therapeutics Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated about 21 hours ago

Cerus Corporation

US
Health and social work services (85)
Updated about 22 hours ago

Maco Pharma International GmbH

DE
Health and social work services (85)
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers